July 28, 2014
VIA EDGAR
Securities and Exchange Commission
Mail Stop 3561
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Pamela Long
| Re: | Vascular Biogenics Ltd. |
| Registration Statement Filed on Form F-1 |
| Registration No. 333-196584 |
Ladies and Gentlemen:
In connection with the above-captioned Registration Statement, we wish to advise that between July 16, 2014 and the date hereof [ ] copies of the Preliminary Prospectus dated July 16, 2014 were distributed as follows: [ ] to institutional investors and [ ] to prospective underwriters, dealers, individuals and others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on July 30, 2014, or as soon thereafter as practicable.
[signature page follows]
Very truly yours,
DEUTSCHE BANK SECURITIES INC. WELLS FARGO SECURITIES, LLC
As Representatives of the several Underwriters
By: Deutsche Bank Securities Inc. | ||
| By: | /s/ John Reed | |
Name: John Reed Title: Director | ||
| By: | /s/ Benjamin Marsh | |
Name: Benjamin Marsh Title: Director | ||
By: Wells Fargo Securities, LLC | ||
| By: | /s/ David Herman | |
Name: David Herman Title: Director | ||
[SIGNATURE PAGE TO ACCELERATION REQUEST OF THE UNDERWRITERS]
